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ACTION OF SYNTHETIC ANTIMALARIAL DRUGS ON PSORIASIS*
THE0D0aE CORNBLEET, M.D.
Since Page employed quinacrine successfully in the treatment of lupus erythematosus
there has been speculation as to how this and related drugs influence this disease. At first
it was thought that the discoloration developed in the skin might screen out harmful light
rays. When succeeding antimalarial drugs, such as chioroquine and hydroxychloroquine,
proved to be even more effective than their predecessor and yet gave colorless solutions, the
idea of light screening as their method of action was abandoned. In spite of these final
negative and a priori conclusions it was found later that the antimalarial drugs were useful,
too, in treating and controlling certain light-sensitive disorders.
Because of these findings and because of the fact that lupus erythematosus, the disease
in which these drugs were first used in dermatology, is a light-sensitive dermatitis, the
absorption spectra of several of these products were studied and charted. In this it was
found that all these drugs are capable of absorbing varying portions of the violet and
ultraviolet bands of the spectrum. It was deduced from these results that one reason the
synthetic antimalarial agents are effective against lupus erythematosus and some of the
other light-sensitive dermatoses was through their capacity to screen out ultraviolet light.
This reasoning led to speculation about what would happen in the case of those diseases
that benefit from exposure to ultraviolet light. Of course, one thinks first of rickets; but
action of the antimalarials here would be somewhat difficult to assess. The dermatologist
probably thinks first of psoriasis. It was therefore decided to make observations on the
effects of the synthetic antimalarial drugs on this dermatosis.
METHOD
Three of these drugs, namely quinacrine, chioroquine, and hydroxychioroquine, were
used simultaneously. The dose of the first was 100 mg., of the second 250 mg., and that of
the third agent 200 mg. All three materials were administered once daily and at the same
time. Six subjects with generalized psoriasis were used for the trials. The results were
more or less the same in all.
RESULTS
No apparent changes developed during the first ten days to two weeks. Soon after that,
however, small, new papules developed at previously unaffected sites. The face, trunk and
extremities became thus involved. At first these tiny, typical psoriatic papules were few, but
later became more numerous. The palms were invariably affected. Here, horny, conical,
deeply set papules were seen to develop apical scales. If the changes were permitted to
advance far enough, the entire palm formed an indurated scaly patch of dermatitis. In the
meantime, older lesions on the skin elsewhere became activated, more acute and lost some
of their scale and enlarged. One patient rapidly developed an exfoliative dermatitis. The
entire activating process was accompanied by itching and some burning. Exposure to
ultraviolet light did not prevent these progressive changes. In fact, it appears this latter
procedure may have quickened the course of events.
When the drugs were discontinued, the evolution of the efflorescence was not halted im-
mediately. In a few days, however, the lesions became stationary. Then there began a re-
cession, varying in speed at different sites and from subject to subject. The usual areas for
psoriasis, scalp, elbows and knees, and lower back, showed the slowest and least regression.
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Of all these, the scalp held its lesions most tenaciously. After three to six weeks from the
time of discontinuing the drugs, the maximum improvement was seen. At this time the
eruption in all patients was improved considerably over what was seen at the start. In two
patients there was total clearing. The impression was gained that the degree of improve-
ment was consonant with the degree to which the eruption was permitted to evolve under
the influence of the drugs. There were no untoward effects other than the worsening of the
psoriasis.
The improvement that followed was in five cases only temporary. The sixth patient
disappeared from observation. It is likely that with other, usual measures used in the treat-
ment of psoriasis the improvement could have been maintained. But with no further ther-
apy, the entire group relapsed again within one to six months. Residue patches grew larger
slowly and new ones appeared. Lesions on the scalp returned most quickly and thickened
more than those at other sites.
When the administration of antimalarial drugs was resumed the previous events could be
induced again. Now, however, they were much slower in appearing and it required larger
doses. All three of the drugs were required in amounts of at least fifty per cent more. Dou-
bling the dose gave more decisive results. Incidentally, only one patient was intolerant
of these larger doses. He complained of nausea and headache, but was able to tolerate
the original dosage schedule.
It is too soon to say what further course the psoriasis will take in this group of subjects.
It may be necessary to give several courses of treatment to achieve complete clearing of the
eruption in some. On the other hand, signs point to an eventual refractory state, where
toxic doses may be required to overcome tolerance.
COMMENT
The method outlined here is not proposed as a practical form of treatment for psoriasis.
So many false starts for the study of psoriasis have been initiated only to prove this is a
most capricious disease, where exact characterizations fit now and here, but fail in other
cases and later. Where an observation, therefore, seems duplicable in this dermatosis, it
would appear worthwhile pursuing.
The logic of these phenomena would seem to revolve about a theme of light. Our most
effective treatment today employs light as a conjunctive measure, or at least an auxiliary
one. Then, too, except for a few cases, psoriaties fare better in summer. A speculative con-
clusion may be that people require varying amounts of light to their well-being. Persons
subject to psoriasis, however, may require relatively extraordinary quantities.
In later communications, details of the experimental physical studies of fluorescene
spectra of antimalarial drugs will be presented. In addition similar observations on coal and
wood tar will be described. Further time will be required, too, to know what further course
this group of patients will pursue and what practical advantages, if any, will accrue from
the use of the synthetic antimalarial drugs.
SUMMAEY
In a group of six patients with generalized psoriasis, synthetic antimalarial drugs in-
duced duplicable effects. The eruption in all became more acute, spread, and in one de-
veloped into exfoliative dermatitis. Following withdrawal of the drugs the skin improved
distinctly to markedly, and cleared entirely in two, but relapsed again after a varying
interval. The antimalarials could again induce a recrudescence, but this second course
took a longer time and larger doses. It was presumed one reason the psoriasis flared under
the influence of antimalarial drugs was because they screened out ultraviolet light. It is
suggested, therefore, that persons prone to psoriasis are obligates of much larger quantities
of light than others for their well-being.
ADDENDUM
Since this paper went to press, I learned of similar work carried out and reported be-
fore ours. Reference: Ziprkowski, Leo, Haim, Salim, and Bank, Harry: Atabrine in psoriasis.
Acta Med. Orient., 13: 45, 1954.
